Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection

NCT04349098 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronavirus Infection

Interventions

DRUG: Selinexor
OTHER: Placebo

Sponsor

Karyopharm Therapeutics Inc